Published in J Exp Med on July 01, 1972
Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. J Clin Invest (1976) 1.95
Properties of a subpopulation of T cells bearing histamine receptors. J Clin Invest (1975) 1.43
T-cell regulation of T-cell responses to antigen. Immunology (1974) 1.37
Tolerance, suppression and the fetal allograft. J Mol Med (Berl) (2004) 1.02
Gamma delta T cells differentiate into a functional but nonproliferative state during a normal immune response. Proc Natl Acad Sci U S A (1993) 0.94
Conformational basis for the activation of adenylate cyclase by adenosine. Proc Natl Acad Sci U S A (1977) 0.90
Alteration in DNA synthetic response of thymocytes from NZB mice of different ages. Proc Natl Acad Sci U S A (1973) 0.85
Suppression of T-cell responses to histocompatibility antigens by BCG pre-treatment. Immunology (1980) 0.81
Augmentation of immune responses after methotrexate administration. Immunology (1979) 0.81
The fate of parental strain small lymphocytes in F1 hybrid rats. Ann N Y Acad Sci (1962) 8.84
The mitotic response of thymus-derived cells to antigenic stimulus. Transplantation (1966) 8.14
Graft versus host reactions. Their natural history, and applicability as tools of research. Prog Allergy (1962) 7.11
Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med (1972) 6.52
Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med (1972) 6.47
Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med (1971) 4.29
Suppressor T cells. J Immunol (1972) 3.92
Antigenic competition between heterologous erythrocytes. I. Thymic dependency. J Immunol (1971) 2.35
Activation of thymus cells by histocompatibility antigens. Nat New Biol (1971) 2.26
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
Cellular immunology and the pathogenesis of graft versus host reactions. Prog Allergy (1971) 1.89
Immunological tolerance as the result of terminal differentiation of immunologically competent cells. Nature (1966) 1.84
Fate of homologous adult spleen cells injected into new-born mice. Nature (1960) 1.75
Specific and nonspecific lymphoid cell proliferation in the pathogenesis of graft-versus-host reactions. Transplantation (1970) 1.47
DISTRIBUTION OF PROLIFERATING DONOR CELLS IN RUNT DISEASE IN RATS. Transplantation (1964) 1.47
Cytological identification of proliferating donor cells in chick embryos injected with adult chicken blood. Nature (1959) 1.31
Immune response suppression by an inhibitor in normal and immune mouse serum. Nat New Biol (1972) 1.30
Cytological estimation of proliferating donor cells during graft-versus-host disease in F1 hybrid mice injected with parental spleen cells. Immunology (1962) 1.23
The DNA synthetic response of adoptively transferred thymocytes in the spleens of lethally irradiated mice. I. Effects of varying antigen and thymocyte doses. J Immunol (1971) 1.17
Primary immune response in grafted cells. Dissociation between the proliferation of activity and the proliferation of cells. J Exp Med (1967) 1.11
THE COMPARATIVE UPTAKE OF I-125-LABELED 5-IODO-2'-DEOXYURIDINE AND THYMIDINE-H3 INTO TISSUES OF MICE BEARING HEPATOMA-129. Cancer Res (1965) 1.04
Antigenic promotion. Increase in hapten-specific plaque-forming cells after pre-injection with structurally unrelated macromolecules. J Exp Med (1971) 1.04
Donor and host contribution to splenomegaly in homologous mouse chimaeras. Nature (1963) 0.98
Reduced sensitivity of F-1 hybrid rats to re-challenge with parental strain spleen cells. Clin Exp Immunol (1966) 0.96
On the mechanism of "homologous disease" in sublethally irradiated mice. Transplantation (1966) 0.88
T cell control of antibody production. Contemp Top Immunobiol (1974) 8.38
Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med (1972) 6.52
Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition. J Exp Med (1978) 6.29
Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology (1970) 6.06
Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J Exp Med (1978) 5.48
Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med (1975) 5.42
Infectious immunological tolerance. Immunology (1971) 5.30
Suppressor T cells. J Immunol (1972) 3.92
Immunological circuits: cellular composition. Fed Proc (1979) 3.72
Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses. J Exp Med (1976) 3.21
A disquisition on suppressor T cells. Transplant Rev (1975) 3.04
Homology and concerted evolution at the alpha 1 and alpha 2 loci of human alpha-globin. Nature (1981) 2.97
Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions. J Exp Med (1975) 2.91
Identification of two KH domain proteins in the alpha-globin mRNP stability complex. EMBO J (1995) 2.87
Contrasuppression. A novel immunoregulatory activity. J Exp Med (1981) 2.84
Cloning and complete nucleotide sequence of human 5'-alpha-globin gene. Proc Natl Acad Sci U S A (1980) 2.62
Immunoregulatory circuits among T-cell sets. Identification of a subpopulation of T-helper cells that induces feedback inhibition. J Exp Med (1978) 2.53
A cellular basis for genetically controlled immunologic unresponsiveness in mice: tolerance induction in T-cells. Proc Natl Acad Sci U S A (1973) 2.52
Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression. J Exp Med (1982) 2.48
Induction of specific suppressor T cells in vitro. J Immunol (1976) 2.44
Detection and characterization of a 3' untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability. Mol Cell Biol (1995) 2.36
Determination of total and merecaptothanol-resistant antibody in the same serum sample. Clin Exp Immunol (1970) 2.36
Antigenic competition between heterologous erythrocytes. I. Thymic dependency. J Immunol (1971) 2.35
beta zero thalassemia in Sardinia is caused by a nonsense mutation. J Clin Invest (1981) 2.30
Immuno-regulatory role of spleen localizing thymocytes. J Immunol (1974) 2.27
The evolution of immunosuppressive cell populations in experimental mycobacterial infection. J Immunol (1978) 2.19
Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody. J Immunol (1971) 2.19
Substrate specificity of the dsRNA unwinding/modifying activity. EMBO J (1991) 2.18
Immunoregulatory T-cell pathways. Annu Rev Immunol (1983) 2.06
Erythroid cell-specific mRNA stability elements in the alpha 2-globin 3' nontranslated region. Mol Cell Biol (1995) 2.04
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest (1999) 2.02
Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med (1980) 1.99
Four highly stable eukaryotic mRNAs assemble 3' untranslated region RNA-protein complexes sharing cis and trans components. Proc Natl Acad Sci U S A (1997) 1.97
Erythroid cell-specific determinants of alpha-globin mRNA stability. Mol Cell Biol (1994) 1.96
Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells. J Immunol (1978) 1.96
Identification of a B-cell surface structure involved in antigen-dependent triggering: absence of this structure on B cells from CBA/N mutant mice. J Exp Med (1977) 1.95
The LIM/double zinc-finger motif functions as a protein dimerization domain. Proc Natl Acad Sci U S A (1994) 1.94
Potentiation of cultured mouse thymocyte responses by factors released by peripheral leucocytes. J Immunol (1971) 1.91
Translationally associated helix-destabilizing activity in rabbit reticulocyte lysate. J Biol Chem (1984) 1.85
Suppressive effects of in vivo immunization on PHA responses in vitro. J Immunol (1974) 1.78
Feedback induction of suppressor T-cell activity. J Exp Med (1975) 1.78
Genetic control of immunoregulatory circuits. Genes linked to the Ig locus govern communication between regulatory T-cell sets. J Exp Med (1979) 1.77
Inactivation of thymus cells after multiple injections of antigen. Nature (1968) 1.72
Activation of suppressor T cells by tumour cells and specific antibody. Nature (1974) 1.67
Assembly of the alpha-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3' untranslated region determinant and poly(C) binding protein alphaCP. Mol Cell Biol (1999) 1.66
T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J Exp Med (1980) 1.65
On concomitant immunity in tumour-bearing hamsters. Nature (1967) 1.59
Intermediary role of macrophages in the passage of suppressor signals between T-cell subsets. J Exp Med (1978) 1.57
The human growth hormone gene is regulated by a multicomponent locus control region. Mol Cell Biol (1995) 1.54
Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and alphaCP-2KL, suggest Distinct modes of RNA recognition. J Biol Chem (2001) 1.53
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J Immunol (1977) 1.45
Differentiation of the mRNA transcripts originating from the alpha 1- and alpha 2-globin loci in normals and alpha-thalassemics. J Clin Invest (1981) 1.43
A native RNA secondary structure controls alternative splice-site selection and generates two human growth hormone isoforms. J Biol Chem (1992) 1.43
Analysis of antigen-specific, Ig-restricted cell-free material made by I-J+ Ly-1 cells (Ly-1 TsiF) that induces Ly-2+ cells to express suppressive activity. Eur J Immunol (1981) 1.42
Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: characterization of an effector cell in the contrasuppressor circuit. Eur J Immunol (1981) 1.40
Targeted recruitment of histone acetyltransferase activity to a locus control region. J Biol Chem (2000) 1.40
Immunosuppression effected by macrophage surfaces. J Immunol (1975) 1.39
T-cell regulation of T-cell responses to antigen. Immunology (1974) 1.37
Globin structural mutant alpha 125Leu leads to Pro is a novel cause of alpha-thalassaemia. Nature (1982) 1.37
Microenvironmental immunoregulation: possible role of contrasuppressor cells in maintaining immune responses in gut-associated lymphoid tissues. Proc Natl Acad Sci U S A (1982) 1.37
Isolation and partial characterization of an antigen-specific T-cell factor associated with the suppression of delayed type hypersensitivity. Proc Natl Acad Sci U S A (1981) 1.36
Analysis of an antigen-specific H-2-restricted cell-free products(s) made by "I-J-" Ly-2 cells (Ly-2 TsF) that suppresses Ly-2 cell-depleted spleen cell activity. Eur J Immunol (1981) 1.34
Induction of suppressor cells in rat spleen: influence of microbial stimulation. J Immunol (1979) 1.31
Immunoregulatory circuits that modulate responsiveness to suppressor cell signal. Failure of B10 mice to respond to suppressor factors can be overcome by quenching the contrasuppressor circuit. J Exp Med (1981) 1.31
DNA synthetic response of thymocytes to a variety of antigens. J Immunol (1972) 1.30
Interleukin 1 can replace the requirement for I-A-positive cells in the proliferation of antigen-primed T cells. Proc Natl Acad Sci U S A (1982) 1.29
Patterns of histone acetylation suggest dual pathways for gene activation by a bifunctional locus control region. EMBO J (2000) 1.28
Evanescent delayed-type hypersensitivity: mediation by effector cells with a short life span. J Immunol (1977) 1.28
Pit-1 binding sites at the somatotrope-specific DNase I hypersensitive sites I, II of the human growth hormone locus control region are essential for in vivo hGH-N gene activation. J Biol Chem (1999) 1.27
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue. Nat Genet (1995) 1.27
Human cysteine-rich protein. A member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J Biol Chem (1992) 1.26
A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog. J Biol Chem (1999) 1.26
Thymus dependence of lymphocyte trapping. J Immunol (1974) 1.25
The human growth hormone gene cluster locus control region supports position-independent pituitary- and placenta-specific expression in the transgenic mouse. J Biol Chem (2000) 1.25
Transfer of an antigen-specific immediate hypersensitivity-like reaction with an antigen-binding factor produced by T cells. Proc Natl Acad Sci U S A (1982) 1.24
PERK-dependent regulation of IAP translation during ER stress. Oncogene (2008) 1.23
Structural and evolutionary analysis of the two chimpanzee alpha-globin mRNAs. Nucleic Acids Res (1983) 1.23
Ly-1 inducer and Ly-1,2 acceptor T cells in the feedback suppression circuit bear an I-J-subregion controlled determinant. Immunogenetics (1980) 1.23
T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii. J Immunol (1982) 1.22
Destabilization of messenger RNA/complementary DNA duplexes by the elongating 80 S ribosome. J Biol Chem (1986) 1.18
Destabilization of human alpha-globin mRNA by translation anti-termination is controlled during erythroid differentiation and is paralleled by phased shortening of the poly(A) tail. J Biol Chem (1997) 1.17
The DNA synthetic response of adoptively transferred thymocytes in the spleens of lethally irradiated mice. I. Effects of varying antigen and thymocyte doses. J Immunol (1971) 1.17
Isolation and partial characterization of antigen-binding molecules produced by in vitro 'educated' T cells. Mol Immunol (1980) 1.14
Identification of two novel mammalian genes establishes a subfamily of KH-domain RNA-binding proteins. Genomics (2000) 1.13
DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proc Natl Acad Sci U S A (1998) 1.13
Antigen-antibody complexes generate Lyt 1 inducers of suppressor cells. J Immunol (1980) 1.11
Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: contrasuppressor cells can convert an in vivo tolerogenic signal into an immunogenic one. Eur J Immunol (1981) 1.11
Interactions between molecules (subfactors) released by different T cell sets that yield a complete factor with biological (suppressive) activity. Proc Natl Acad Sci U S A (1982) 1.11
Tolerance to sheep red cells: breakage with thymocytes and horse red cells. Science (1972) 1.09
Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med (1983) 1.08
Two distinct species of human growth hormone-variant mRNA in the human placenta predict the expression of novel growth hormone proteins. J Biol Chem (1988) 1.08
Localization of leucocytes in sites of delayed-type hypersensitivity and in lymph nodes: dependence on vasoactive amines. Immunology (1982) 1.08
Studies on homotransplantable lymphomas in hamsters. I. Histologic responses in lymphoid tissues and their relationship to metastasis. Am J Pathol (1966) 1.07
The stability of human beta-globin mRNA is dependent on structural determinants positioned within its 3' untranslated region. Blood (1996) 1.06
B cell-deprived mice lack functional expression of certain T suppressor cell subsets. J Mol Cell Immunol (1984) 1.06
Human alpha-globin genes demonstrate autonomous developmental regulation in transgenic mice. Mol Cell Biol (1991) 1.05